REFERENCES
2. Ndumele CE, Neeland IJ, Tuttle KR, et al. ; American Heart Association. A Synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148:1636-64.
3. Larqué E, Labayen I, Flodmark CE, et al. From conception to infancy - early risk factors for childhood obesity. Nat Rev Endocrinol. 2019;15:456-78.
4. Baccarelli AA, Ordovás J. Epigenetics of early cardiometabolic disease: mechanisms and precision medicine. Circ Res. 2023;132:1648-62.
5. Grassi D, Ferri C. Aortic stiffness, blood pressure and renal dysfunction. Intern Emerg Med. 2011;6 Suppl 1:111-4.
6. Zheng M, Zhang X, Chen S, et al. Arterial stiffness preceding diabetes: a longitudinal study. Circ Res. 2020;127:1491-8.
7. Regnault V, Lacolley P, Laurent S. Arterial stiffness: from basic primers to integrative physiology. Annu Rev Physiol. 2024;86:99-121.
8. Quiles J, Morillas P, Bertomeu V, et al. ; Prevalence of Peripheral Arterial Disease in Patients with Acute Coronary Syndrome (PAMISCA) Investigators. Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome. Int J Cardiol. 2011;151:84-8.
9. Voicehovska JG, Bormane E, Grigane A, et al. Association of arterial stiffness with chronic kidney disease progression and mortality. Heart Lung Circ. 2021;30:1694-701.
10. Daschner C, Kleber ME, Stach K, et al. Association between arterial stiffness, carbamylation, and mortality in patients undergoing coronary angiography with no or mild chronic kidney disease. Cardiorenal Med. 2025;15:83-97.
11. Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63:636-46.
12. Williams B, Mancia G, Spiering W, et al. ; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-104.
13. Vlachopoulos C, Terentes-Printzios D, Laurent S, et al. Association of estimated pulse wave velocity with survival: a secondary analysis of SPRINT. JAMA Netw Open. 2019;2:e1912831.
14. Vishram-Nielsen JKK, Laurent S, Nilsson PM, et al. ; MORGAM Project. Does estimated pulse wave velocity add prognostic information? : MORGAM prospective cohort project. Hypertension. 2020;75:1420-8.
15. Liu Y, Xu K, Wu S, Qin M, Liu X. Value of estimated pulse wave velocity to identify left ventricular hypertrophy prevalence: insights from a general population. BMC Cardiovasc Disord. 2022;22:157.
16. Cui X, Shi H, Hu Y, et al. Association between estimated pulse wave velocity and in-hospital and one-year mortality of patients with chronic kidney disease and atherosclerotic heart disease: a retrospective cohort analysis of the MIMIC-IV database. Renal Fail. 2024;46:2387932.
17. Ji C, Gao J, Huang Z, et al. Estimated pulse wave velocity and cardiovascular events in Chinese. Int J Cardiol Hypertens. 2020;7:100063.
18. Heffernan KS, Jae SY, Loprinzi PD. Association between estimated pulse wave velocity and mortality in U.S. adults. J Am Coll Cardiol. 2020;75:1862-4.
19. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/nhanes/index.htm. (accessed 15 December 2025).
20. Centers for Disease Control and Prevention, NCHS Ethics Review Board (ERB) Approval. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/nchs/nhanes/about/erb.html. (accessed 22 December 2025).
21. Kirkendall WM, Burton AC, Epstein FH, Freis ED. Recommendations for human blood pressure determination by sphygmomanometers. Circulation. 1967;36:980-8.
22. Aimagambetova B, Ariko T, Gardener H, et al. Association of estimated pulse wave velocity with cognitive function in a multiethnic diverse population: the Northern Manhattan study. Alzheimers Dement. 2024;20:4903-13.
24. Inker LA, Eneanya ND, Coresh J, et al. ; Chronic Kidney Disease Epidemiology Collaboration. New creatinine- and cystatin c-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737-49.
25. Khan SS, Coresh J, Pencina MJ, et al. ; American Heart Association. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148:1982-2004.
26. Stevens PE, Levin A. ; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825-30.
27. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98:Suppl S1-S115.
28. Ndumele CE, Rangaswami J, Chow SL, et al. ; American Heart Association. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148:1606-35. 0000000000001184].
29. Johnson CL, Paulose-Ram R, Ogden CL, et al. National health and nutrition examination survey: analytic guidelines, 1999-2010. Vital Health Stat 2. 2013;161:1-24.
30. Zhang YB, Chen C, Pan XF, et al. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021;373:n604.
31. Linzer DA, Lewis JB. poLCA: an R package for polytomous variable latent class analysis. J Stat Soft. 2011;42:1-29.
32. Liu Y, Ge X, Wang Y, Qiao S, Cai Y. How race and socioeconomic status moderate the association between moderate-to-vigorous physical activity and depressive symptoms: a cross-sectional study with compositional data. Br J Sports Med. 2024;58:1401-8.
33. Guenther PM, Casavale KO, Reedy J, et al. Update of the healthy eating index: HEI-2010. J Acad Nutr Diet. 2013;113:569-80.
34. McGuire S. U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr. 2011;2:293-4.
35. Statistics. NCfH. NHANES survey methods and analytic guidelines. US Centers for Disease Control and Prevention. Available from: https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. (accessed 15 December 2025).
36. Liu Y, De A. Multiple imputation by fully conditional specification for dealing with missing data in a large epidemiologic study. Int J Stat Med Res. 2015;4:287-95.
37. Lee KJ, Carlin JB. Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation. Am J Epidemiol. 2010;171:624-32.
38. Hametner B, Wassertheurer S, Mayer CC, Danninger K, Binder RK, Weber T. Aortic pulse wave velocity predicts cardiovascular events and mortality in patients undergoing coronary angiography: a comparison of invasive measurements and noninvasive estimates. Hypertension. 2021;77:571-81.
39. Sequí-Domínguez I, Cavero-Redondo I, Álvarez-Bueno C, Pozuelo-Carrascosa DP, Nuñez de Arenas-Arroyo S, Martínez-Vizcaíno V. Accuracy of pulse wave velocity predicting cardiovascular and all-cause mortality. A systematic review and meta-analysis. J Clin Med. 2020;9:2080.
40. Starzak M, Stanek A, Jakubiak GK, Cholewka A, Cieślar G. Arterial stiffness assessment by pulse wave velocity in patients with metabolic syndrome and its components: is it a useful tool in clinical practice? Int J Environ Res Public Health. 2022;19 :10368.
41. Beros A, Sluyter J, Hughes A, Hametner B, Wassertheurer S, Scragg R. Arterial stiffness and incident chronic kidney disease: a large population-based cohort study. J Nephrol. 2024;37:1241-50.
43. Ejiri K, Ding N, Kim E, et al. Association of segment-specific pulse wave velocity with vascular calcification: The ARIC (Atherosclerosis Risk in Communities) study. J Am Heart Assoc. 2024;13:e031778.
44. Lo Cicero L, Lentini P, Sessa C, et al. Inflammation and arterial stiffness as drivers of cardiovascular risk in kidney disease. Cardiorenal Med. 2025;15:29-40.
45. Vervloet MG. Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers? Clin Kidney J. 2023;16:1766-75.
46. Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:1237-63.
47. Schraml C, Schwenzer NF, Martirosian P, Claussen CD, Schick F. Perfusion imaging of the pancreas using an arterial spin labeling technique. J Magn Reson Imaging. 2008;28:1459-65.
48. Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36:166-75.
49. Jahn LA, Hartline L, Liu Z, Barrett EJ. Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome. Am J Physiol Endocrinol Metab. 2022;322:E173-80.
50. Tian X, Zuo Y, Chen S, et al. Hypertension, arterial stiffness, and diabetes: a prospective cohort study. Hypertension. 2022;79:1487-96.
51. Giannakodimos A, Oikonomou E, Pantelidis P, et al. Arterial stiffness as a complication of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2025;19:413-26.
52. Kim BS, Kim HJ, Shin JH. Association between estimated pulse wave velocity and incident nonalcoholic fatty liver disease in korean adults. Pulse (Basel). 2024;12:1-11.
53. Byrne CD, Armandi A, Pellegrinelli V, Vidal-Puig A, Bugianesi E. Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment. Nat Rev Gastroenterol Hepatol. 2025;22:314-28.
54. Manolis AA, Manolis TA, Vouliotis A, Manolis AS. Metabolic dysfunction-associated steatotic liver disease and the cardiovascular system. Trends Cardiovasc Med. 2025;35:258-65.
55. Huang DQ, Wong VWS, Rinella ME, et al. Metabolic dysfunction-associated steatotic liver disease in adults. Nat Rev Dis Primers. 2025;11:14.
56. Cossins BC, van den Munckhof I, Rutten JHW, et al. Sex-specific association between adipose tissue inflammation and vascular and metabolic complications of obesity. J Clin Endocrinol Metab. 2023;108:2537-49.
57. Cherubini A, Della Torre S, Pelusi S, Valenti L. Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease. Trends Mol Med. 2024;30:1126-36.
58. Dileo E, Saba F, Parasiliti-Caprino M, Rosso C, Bugianesi E. Impact of sexual dimorphism on therapy response in patients with metabolic dysfunction-associated steatotic liver disease: from conventional and nutritional approaches to emerging therapies. Nutrients. 2025;17:477.
59. DuPont JJ, Kenney RM, Patel AR, Jaffe IZ. Sex differences in mechanisms of arterial stiffness. Br J Pharmacol. 2019;176:4208-25.
60. Flack JM, Sica DA, Bakris G, et al. ; International society on hypertension in blacks. management of high blood pressure in blacks: an update of the international society on hypertension in Blacks consensus statement. Hypertension. 2010;56:780-800.
61. Li J, Lei L, Wang W, et al. Social risk profile and cardiovascular-kidney-metabolic syndrome in US adults. J Am Heart Assoc. 2024;13:e034996.
